Original language | English (US) |
---|---|
Pages (from-to) | 487-494 |
Number of pages | 8 |
Journal | Rheumatology (United Kingdom) |
Volume | 59 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2020 |
Keywords
- diagnosis
- giant cell arteritis
- guidelines
- investigations
- large-vessel vasculitis
- temporal arteritis
- treatment This is the executive summary of British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis, doi: 10.1093/rheumatology/kez672
ASJC Scopus subject areas
- Rheumatology
- Pharmacology (medical)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis : Executive summary. / MacKie, Sarah L.; Dejaco, Christian; Appenzeller, Simone; Camellino, Dario; Duftner, Christina; Gonzalez-Chiappe, Solange; Mahr, Alfred; Mukhtyar, Chetan; Reynolds, Gary; De Souza, Alexandre Wagner S.; Brouwer, Elisabeth; Bukhari, Marwan; Buttgereit, Frank; Byrne, Dorothy; Cid, Maria C.; Cimmino, Marco; Direskeneli, Haner; Gilbert, Kate; Kermani, Tanaz A.; Khan, Asad; Lanyon, Peter; Luqmani, Raashid; Mallen, Christian; Mason, Justin C.; Matteson, Eric L.; Merkel, Peter A.; Mollan, Susan; Neill, Lorna; Sullivan, Eoin O.; Sandovici, Maria; Schmidt, Wolfgang A.; Watts, Richard; Whitlock, Madeline; Yacyshyn, Elaine; Ytterberg, Steven; Dasgupta, Bhaskar.
In: Rheumatology (United Kingdom), Vol. 59, No. 3, 01.03.2020, p. 487-494.Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis
T2 - Executive summary
AU - MacKie, Sarah L.
AU - Dejaco, Christian
AU - Appenzeller, Simone
AU - Camellino, Dario
AU - Duftner, Christina
AU - Gonzalez-Chiappe, Solange
AU - Mahr, Alfred
AU - Mukhtyar, Chetan
AU - Reynolds, Gary
AU - De Souza, Alexandre Wagner S.
AU - Brouwer, Elisabeth
AU - Bukhari, Marwan
AU - Buttgereit, Frank
AU - Byrne, Dorothy
AU - Cid, Maria C.
AU - Cimmino, Marco
AU - Direskeneli, Haner
AU - Gilbert, Kate
AU - Kermani, Tanaz A.
AU - Khan, Asad
AU - Lanyon, Peter
AU - Luqmani, Raashid
AU - Mallen, Christian
AU - Mason, Justin C.
AU - Matteson, Eric L.
AU - Merkel, Peter A.
AU - Mollan, Susan
AU - Neill, Lorna
AU - Sullivan, Eoin O.
AU - Sandovici, Maria
AU - Schmidt, Wolfgang A.
AU - Watts, Richard
AU - Whitlock, Madeline
AU - Yacyshyn, Elaine
AU - Ytterberg, Steven
AU - Dasgupta, Bhaskar
N1 - Funding Information: Funding: The British Society for Rheumatology provided financial support for this guideline. Funding Information: Christian Dejaco – Consultancy fees and honoraries from Roche, Sanofi, AbbVie, MSD, Pfizer, UCB and Bristol-Myers Squibb, first author of EULAR imaging recommendations in large vessel vasculitis, first author of ACR/EULAR recommendations for management of PMR, co-author of management recommendations for large vessel vasculitis. Simone Appenzeller – None. Dario Camellino – Travel expenses, consultancy and speaker fees from AbbVie, Celgene, Janssen-Cilag, Eli Lilly, Mylan and Sanofi. Christina Duftner – None. Solange Gonzalez-Chiappe – None. Alfred Mahr – Honoraria for advisory board meetings and lectures from Chugai Pharma France. Chetan Mukhtyar – None. Gary Reynolds – None. Alexandre Wagner S. de Souza – None. Elisabeth Brouwer – Employee of the University Medical Center Groningen, Groningen, The Netherlands. Part of the work is funded by Reuma Nederland. Lead author in the development of local and national guidelines for GCA in The Netherlands. Marwan Bukhari – Involvement in the GCA Consortium, which is indirectly funded by Roche/ Chugai. Virtual Advisory Board Member for Roche/ Chugai on GCA. Frank Buttgereit – Consultancy fees, honoraria and/or travel expenses from Horizon Pharma, Mundipharma, Roche and Pfizer and grant/study support from Horizon Pharma and Mundipharma. Dorothy Byrne – Vice Chair of PMRGCAuk. Maria C. Cid – Research grant from Kiniksa and consulting fees from AbbVie and Janssen. Participated in clinical trials sponsored by GlaxoSmithKline and Kiniksa. Co-author in publications of work sponsored by Roche. Marco Cimmino – None. Haner Direskeneli – Local Advisory Board Member for Roche for GCA. Kate Gilbert – Representative of PMRGCAuk. Tanaz A. Kermani – Consultancy for AbbVie in March 2018. Asad Khan – Speaker fees from Chugai. Peter Lanyon – Former president of the BSR April 2016–18, chair of the Rare Autoimmune Rheumatic Disease Alliance (RAIRDA). Raashid Luqmani – Grants, honoraria and travel support for EULAR 2019 from Roche/Chugai. Christian Mallen – None. Justin C. Mason – Speaker fees and consultancy fees from Roche/Chugai. Eric L. Matteson – None. Peter A. Merkel – Consulting fees from AbbVie, AstraZeneca, Biogen, Boeringher-Ingelheim, Bristol-Myers Squibb, Celgene, ChemoCentryx, CSL Behring, Genentech/ Roche, Genzyme/Sanofi, GlaxoSmithKline, InflaRx, Insmed, Janssen and Kiniksa and research support from Bristol-Myers Squibb and Genentech/Roche/Chugai. Susan Mollan – Advisory boards and speaker fees from Roche/Chugai. Representative from the Royal College of Ophthalmologists, co-author of the EULAR GCA guideline group and co-author of the European Headache Federation GCA guideline group. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/3/1
Y1 - 2020/3/1
KW - diagnosis
KW - giant cell arteritis
KW - guidelines
KW - investigations
KW - large-vessel vasculitis
KW - temporal arteritis
KW - treatment This is the executive summary of British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis, doi: 10.1093/rheumatology/kez672
UR - http://www.scopus.com/inward/record.url?scp=85080843356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080843356&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/kez664
DO - 10.1093/rheumatology/kez664
M3 - Review article
C2 - 31970410
AN - SCOPUS:85080843356
VL - 59
SP - 487
EP - 494
JO - Rheumatology (United Kingdom)
JF - Rheumatology (United Kingdom)
SN - 1462-0324
IS - 3
ER -